国药控股:国药器械前三季度归母净利润约6.78亿元 同比降低11.88%

Sinopharm Holdings: Sinopharm's net profit for the first three quarters was about 678 million yuan, a year-on-year decrease of 11.88%

新浪港股 ·  10/26/2023 17:01

Sinopharm Holdings (01099) announced the results of Sinopharm Devices for the nine months ended September 30, 2023. The group obtained revenue of 60.222 billion yuan (RMB, same below) during the period, an increase of 10.43% over the previous year; the total comprehensive income attributable to owners of the parent company was about 678 million yuan, a decrease of 11.88% over the previous year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment